Next Article in Journal
Antitumor Properties of Epitope-Specific Engineered Vaccine in Murine Model of Melanoma
Next Article in Special Issue
Biochemical Characterization and Elucidation of the Hybrid Action Mode of a New Psychrophilic and Cold-Tolerant Alginate Lyase for Efficient Preparation of Alginate Oligosaccharides
Previous Article in Journal
A Paternal Fish Oil Diet Preconception Modulates the Gut Microbiome and Attenuates Necrotizing Enterocolitis in Neonatal Mice
Previous Article in Special Issue
Multi-Step Enzymatic Production and Purification of 2-Keto-3-Deoxy-Galactonate from Red-Macroalgae-Derived Agarose
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 20
Issue 6
10.3390/md20060391
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Anti-Inflammatory Effect of Sulfated Polysaccharides Isolated from Codium fragile In Vitro in RAW 264.7 Macrophages and In Vivo in Zebrafish

by
Lei Wang
1,
Jun-Geon Je
2,
Caoxing Huang
3,
Jae-Young Oh
4,
Xiaoting Fu
1,
Kaiqiang Wang
1,5,
Ginnae Ahn
6,
Jiachao Xu
1,
Xin Gao
1 and
You-Jin Jeon
2,7,*
1
College of Food Science and Engineering, Ocean University of China, Qingdao 266003, China
2
Department of Marine Life Sciences, Jeju National University, Jeju 63243, Korea
3
Co-Innovation Center for Efficient Processing and Utilization of Forest Products, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China
4
Food Safety and Processing Research Division, National Institute of Fisheries Science, Busan 46083, Korea
5
Fujian Provincial Key Laboratory of Breeding Lateolabrax Japonicus, Fujian 355299, China
6
Department of Marine Bio Food Science, Chonnam National University, Yeosu 59626, Korea
7
Marine Science Institute, Jeju National University, Jeju 63333, Korea
*
Author to whom correspondence should be addressed.
Mar. Drugs 2022, 20(6), 391; https://doi.org/10.3390/md20060391
Submission received: 23 March 2022 / Revised: 10 June 2022 / Accepted: 11 June 2022 / Published: 13 June 2022
(This article belongs to the Special Issue Advances in Oligosaccharides and Polysaccharide Modifications in Marine Bioresources)
Browse Figures
Versions Notes

Abstract

:
In this study, the anti-inflammatory activity of sulfated polysaccharides isolated from the green seaweed Codium fragile (CFCE-PS) was investigated in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages and zebrafish. The results demonstrated that CFCE-PS significantly increased the viability of LPS-induced RAW 264.7 cells in a concentration-dependent manner. CFCE-PS remarkably and concentration-dependently reduced the levels of inflammatory molecules including prostaglandin E2, nitric oxide (NO), interleukin-1 beta, tumor necrosis factor-alpha, and interleukin-6 in LPS-stimulated RAW 264.7 cells. In addition, in vivo test results indicated that CFCE-PS effectively reduced reactive oxygen species, cell death, and NO levels in LPS-stimulated zebrafish. Thus, these results indicate that CFCE-PS possesses in vitro and in vivo anti-inflammatory activities and suggest it is a potential ingredient in the functional food and pharmaceutical industries.

1. Introduction

Inflammatory responses are immune responses that protect the organs from infection and tissue injury. Inflammatory responses are also associated with the pathogenesis of various diseases such as diabetes, cardiovascular diseases, obesity, arthritis, stroke, and cancer [1]. Inflammatory responses are associated with the release of inflammatory molecules such as histamine, prostaglandins, nitric oxide (NO), bradykinin, and pro-inflammatory cytokines [2]. The over-generation of these inflammatory molecules can cause uncontrolled inflammation, which leads to chronic inflammation and promotes the development of chronic inflammation-related diseases [3,4,5]. Thus, the inhibition of the production of inflammatory molecules is thought as a way to control the development of inflammation.
Seaweeds are rich in bioactive compounds. Seaweed-derived compounds possess several health benefits such as antiviral, anti-aging, antioxidant, anti-cancer, anti-obesity, anti-inflammatory, and anti-hypertensive effects [6,7]. Sulfated polysaccharides isolated from seaweeds possess strong anti-inflammatory activities [8,9]. Lipopolysaccharide (LPS), a component of the cell wall in Gram-negative bacteria, stimulates inflammatory responses. Thus, LPS-stimulated in vitro and in vivo models were used to investigate the anti-inflammatory activities of natural products. Sanjeewa et al. isolated a sulfated polysaccharide from the brown seaweed Sargassum horneri, which could inhibit lipopolysaccharide (LPS)-stimulated inflammation in RAW 264.7 cells and zebrafish [10]. Cui et al. purified a sulfated polysaccharide from Gelidium pacificum Okamura, which could suppress LPS-stimulated inflammation in human monocytic cells [8]. Rodrigues et al. investigated the anti-inflammation effect of the sulfated polysaccharide isolated from Caulerpa cupressoides (Cc-SP2). The results suggested that Cc-SP2 effectively suppressed acute inflammation in mice [9].
Codium fragile is a popular edible green seaweed. C. fragile contains various bioactive compounds such as fatty acids, carbohydrates, pigments, phenolic compounds, and proteins [11,12]. The anti-coagulation, antioxidant, anti-angiogenesis, anti-obesity, and immunoregulatory activities of C. fragile have been reported [13,14,15]. In previous studies, we evaluated the antioxidant activity of sulfated polysaccharides isolated from an enzymatic digest of C. fragile (CFCE-PS). The results demonstrated that CFCE-PS significantly suppressed hydrogen peroxide-induced oxidative damage in in vitro and in vivo models [16]. To further investigate the bioactivities of CFCE-PS, we evaluated the anti-inflammatory activity of CFCE-PS in LPS-stimulated RAW 264.7 cells and zebrafish.

2. Results and Discussion

2.1. CFCE-PS Suppressed Cytotoxicity and Inflammatory Molecules Production in LPS-Induced RAW 264.7 Cells

Sulfated polysaccharides isolated from seaweeds possess strong anti-inflammatory and immunostimulatory effects [17,18]. The anti-inflammatory activities of sulfated polysaccharides isolated from seaweeds, such as Saccharina japonica, Sargassum horneri, Padina commersonii, and Chnoospora minima have been investigated in our previous studies [19,20,21,22]. The results further confirm the potential of seaweed-derived sulfated polysaccharides in anti-inflammatory effects. Thus, in the present study, we evaluated the anti-inflammatory activity of CFCE-PS in in vitro and in vivo models.
In the present study, the effects of CFCE-PS on LPS-induced cytotoxicity and inflammatory molecule production were evaluated. As shown in Figure 1A, the viability of LPS-stimulated RAW 264.7 cells was decreased to 78.84% compared to the cells non-treated with sample and LPS (control group, 100%), whereas the viabilities of the LPS-treated RAW 264.7 cells were increased to 84.36, 85.55, and 89.90% by CFCE-PS at concentrations of 25, 50, and 100 μg/mL, respectively (Figure 1A). In addition, LPS significantly stimulated the production of NO and prostaglandin E2 (PGE2) in RAW 264.7 cells (Figure 1B,C). However, the production of NO and PGE2 in LPS-treated RAW 264.7 cells was significantly reduced by CFCE-PS treatment in a concentration-dependent manner (Figure 1B,C). As shown in Figure 2, LPS significantly stimulated the production of pro-inflammatory cytokines including interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) in RAW 264.7 cells. However, the production of these pro-inflammatory cytokines in RAW 264.7 cells was effectively suppressed by CFCE-PS treatment in a concentration-dependent manner (Figure 2). These results indicate that CFCE-PS protected RAW 264.7 cells against LPS-stimulated cell death by inhibiting inflammatory molecule production.
Anti-inflammatory effects of the algal sulfated polysaccharides were related to their sulfated content and proportion of monosaccharides. Previous reports suggested that the polysaccharides contain high amounts of the sulfate group, fucose, and galactose, which could inhibit the LPS-induced inflammatory response in RAW 264.7 cells [23,24,25,26,27]. CFCE-PS contains 21.06% sulfate and 70.19% galactose, and significantly inhibited the production of the inflammatory molecules in LPS-stimulated RAW 264.7 cells. According to the previous and present results, CFCE-PS suppressed LPS-stimulated cytotoxicity and the production of inflammatory molecules in RAW 264.7 cells. This action may be due to it containing a high amount of the sulfate group and galactose.

2.2. Protective Effect of CFCE-PS against LPS-Stimulated Inflammatory Response in Zebrafish

LPS-stimulated zebrafish embryo has been successfully used to investigate the in vivo anti-inflammatory effects of sulfated polysaccharides in our previous studies [21]. Therefore, in this study, the LPS-stimulated zebrafish embryo was used as the in vivo model to investigate the anti-inflammatory effect of CFCE-PS. As shown in Figure 3, the survival rate of LPS-stimulated zebrafish decreased to 56.67% compared to the control group (100%), whereas the survival rates of zebrafish treated with 50 and 100 μg/mL CFCE-PS were remarkably increased to 63.33 and 73.33%, respectively (Figure 3). In addition, the ROS level of LPS-treated zebrafish was increased to 172.65% compared to the control group (100%). However, the levels of ROS in CFCE-PS-treated zebrafish were significantly decreased in a dose-dependent manner (Figure 4A). As shown in Figure 4B, LPS significantly stimulated cell death in zebrafish, whereas the cell death levels of zebrafish treated with 25, 50, and 100 μg/mL CFCE-PS were decreased from 295.22% to 277.72, 217.68, and 185.58%, respectively (Figure 4B). Furthermore, the NO production level of zebrafish stimulated with LPS was increased to 220.45% compared to the control group (100%). However, the NO level of LPS-stimulated zebrafish was reduced to 172.99, 154.53, and 133.51% by the treatment of 25, 50, and 100 μg/mL CFCE-PS, respectively (Figure 4C). These results demonstrate that CFCE-PS remarkably protected zebrafish against LPS-stimulated inflammation.
In summary, in this study, the in vitro and in vivo anti-inflammatory effects of CFCE-PS were evaluated in LPS-stimulated RAW 264.7 cells and zebrafish. The results indicate that CFCE-PS inhibited LPS-induced inflammatory response by inhibiting the production of NO and PGE2, and decreasing the levels of pro-inflammatory cytokines in RAW 264.7 cells. In addition, the in vivo test showed that CFCE-PS remarkably suppressed the survival rate and reduced the levels of ROS, cell death, and NO in LPS-stimulated zebrafish. These results indicate that CFCE-PS possesses in vitro and in vivo anti-inflammatory effects. It could be used as a functional material in food and pharmaceutical industries.

3. Materials and Methods

3.1. Reagents and Chemicals

LPS, MTT, and DMSO were purchased from Sigma-Aldrich (St. Louis, MO, USA). Enzyme-linked immunosorbent assay (ELISA) kits used for measurement of IL-1β, TNF-α, PGE2, and IL-6 were purchased from R&D Systems Inc. (Minneapolis, MN, USA).

3.2. Preparation of CFCE-PS

C. fragile was collected in June 2019 from the coastal area of Jeju Island, South Korea. CFCE-PS was prepared based on the protocol described in the previous study [16]. CFCE-PS contained 76.84% sulfated polysaccharides, including 21.06% sulfate and 55.78% carbohydrates, which were composed of galactose (70.19%), arabinose (18.71%), glucose (9.10%), and xylose (1.99%).

3.3. Measurement of NO Level and Cell Viability

RAW 264.7 macrophages (RAW 264.7 cells, TIB-71TM) were purchased from ATCC (Manassas, WV, USA). Cells were seeded in a 24-well plate (1 × 105 cells/mL) for 24 h. The cells were treated with 25, 50, and 100 µg/mL CFCE-PS. The cells non-treated with CFCE-PS and LPS are referred to as the control group. CFCE-PS-treated cells were incubated for 1 h and the plate was replaced with the media containing 1 µg/mL LPS. After 24 h incubation, the viability of LPS-treated RAW264.7 cells was measured using an MTT assay, and the production of NO was determined using a Griess assay [28].

3.4. ELISA

RAW 264.7 cells were seeded in a 24-well plate (1 × 105 cells/mL) for 24 h. The cells were treated with 25, 50, and 100 µg/mL CFCE-PS. CFCE-PS-treated cells were incubated for 1 h and stimulated with 1 µg/mL LPS. After 24 h, the cell culture media was collected. The levels of pro-inflammatory cytokines and PGE2 were evaluated using ELISA kits [28].

3.5. Application of CFCE-PS and LPS to Zebrafish

The adult zebrafish were purchased from a commercial market (Seoul Aquarium, Korea) and maintained according to the condition described in our previous study [29]. After approximately 7–9 h of post-fertilization (hpf), the embryos were treated with 25, 50, and 100 μg/mL CFCE-PS. After 1 h of incubation, the embryos were incubated with the media containing 10 µg/mL LPS until 24 hpf. The zebrafish non-treated with CFCE-PS and LPS are referred to as the control group. The survival rate of zebrafish was measured at 3 days post-fertilization. The levels of cell death, ROS, and NO in LPS-induced zebrafish were measured in live zebrafish larvae by acridine orange, DCFH2-DA, and DAF-FM-DA staining, respectively [30].

3.6. Statistical Analysis

The experiments were conducted in triplicate and the data are expressed as the mean ± standard error (SE). One-way analysis of variance used to compare the mean values of each treatment using SPSS 20.0. Significant differences between the means were estimated using Tukey’s test.

4. Conclusions

In this study, the in vitro and in vivo anti-inflammatory activities of sulfated polysaccharides of the edible seaweed C. fragile (CFCE-PS) were investigated. The results demonstrated that CFCE-PS effectively inhibited LPS-stimulated inflammation in vitro in RAW 264.7 cells and in vivo in zebrafish. These results suggest that CFCE-PS is a potential anti-inflammatory ingredient in functional food and the pharmaceutical industry. However, to develop CFCE-PS as a therapeutic agent to treat inflammatory-related diseases, the clinical study is vital in further research.

Author Contributions

L.W., G.A. and Y.-J.J. designed this study. L.W., X.F. and Y.-J.J. wrote the manuscript. L.W., J.-Y.O., K.W. and J.-G.J. performed the experiments. L.W., C.H., J.X. and X.G. analyzed the data. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Start-up Fund for Young-talent Program (Grant No.: 862101013159) funded by the Ocean University of China, the Qingdao Postdoctoral Applied Research Project (Grant No.: 862105040061), and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant No.:2019R1A6A1A03033553).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sanjeewa, K.K.A.; Herath, K.H.I.N.M.; Yang, H.-W.; Choi, C.S.; Jeon, Y.-J. Anti-Inflammatory Mechanisms of Fucoidans to Treat Inflammatory Diseases: A Review. Mar. Drugs 2021, 19, 678. [Google Scholar] [CrossRef]
  2. Li, Z.; Wang, K.; Ji, X.; Wang, H.; Zhang, Y. ACE2 suppresses the inflammatory response in LPS-induced porcine intestinal epithelial cells via regulating the NF-κB and MAPK pathways. Peptides 2022, 149, 170717. [Google Scholar] [CrossRef]
  3. Lima Correa, B.; El Harane, N.; Gomez, I.; Rachid Hocine, H.; Vilar, J.; Desgres, M.; Bellamy, V.; Keirththana, K.; Guillas, C.; Perotto, M.; et al. Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts. Cardiovasc. Res. 2021, 117, 292–307. [Google Scholar] [CrossRef]
  4. Ryu, D.H.; Cho, J.Y.; Sadiq, N.B.; Kim, J.-C.; Lee, B.; Hamayun, M.; Lee, T.S.; Kim, H.S.; Park, S.H.; Nho, C.W.; et al. Optimization of antioxidant, anti-diabetic, and anti-inflammatory activities and ganoderic acid content of differentially dried Ganoderma lucidum using response surface methodology. Food Chem. 2020, 335, 127645. [Google Scholar] [CrossRef]
  5. Hirano, T. IL-6 in inflammation, autoimmunity and cancer. Int. Immunol. 2021, 33, 127–148. [Google Scholar] [CrossRef]
  6. Rajauria, G.; Ravindran, R.; Garcia-Vaquero, M.; Rai, D.K.; Sweeney, T.; O’Doherty, J. Molecular characteristics and antioxidant activity of laminarin extracted from the seaweed species Laminaria hyperborea, using hydrothermal-assisted extraction and a multi-step purification procedure. Food Hydrocoll. 2020, 112, 106332. [Google Scholar] [CrossRef]
  7. Zhong, Q.-W.; Zhou, T.-S.; Qiu, W.-H.; Wang, Y.-K.; Xu, Q.-L.; Ke, S.-Z.; Wang, S.-J.; Jin, W.-H.; Chen, J.-W.; Zhang, H.-W.; et al. Characterization and hypoglycemic effects of sulfated polysaccharides derived from brown seaweed Undaria pinnatifida. Food Chem. 2020, 341, 128148. [Google Scholar] [CrossRef]
  8. Cui, M.; Wu, J.; Wang, S.; Shu, H.; Zhang, M.; Liu, K.; Liu, K. Characterization and anti-inflammatory effects of sulfated polysaccharide from the red seaweed Gelidium pacificum Okamura. Int. J. Biol. Macromol. 2019, 129, 377–385. [Google Scholar] [CrossRef]
  9. Rodrigues, J.A.G.; Vanderlei, E.D.S.; Silva, L.M.; De Araújo, I.W.; De Queiroz, I.N.; De Paula, G.A.; Abreu, T.M.; Ribeiro, N.A.; Bezerra, M.M.; Chaves, H.V.; et al. Antinociceptive and anti-inflammatory activities of a sulfated polysaccharide isolated from the green seaweed Caulerpa cupressoides. Pharmacol. Rep. 2012, 64, 282–292. [Google Scholar] [CrossRef]
  10. Sanjeewa, K.K.A.; Jayawardena, T.U.; Kim, S.-Y.; Kim, H.-S.; Ahn, G.; Kim, J.; Jeon, Y.-J. Fucoidan isolated from invasive Sargassum horneri inhibit LPS-induced inflammation via blocking NF-κB and MAPK pathways. Algal Res. 2019, 41, 101561. [Google Scholar] [CrossRef]
  11. Ahn, J.; Kim, M.J.; Yoo, A.; Ahn, J.; Ha, T.Y.; Jung, C.H.; Seo, H.D.; Jang, Y.J. Identifying Codium fragile extract components and their effects on muscle weight and exercise endurance. Food Chem. 2021, 353, 129463. [Google Scholar] [CrossRef]
  12. Kim, J.; Choi, J.H.; Oh, T.; Ahn, B.; Unno, T. Codium fragile Ameliorates High-Fat Diet-Induced Metabolism by Modulating the Gut Microbiota in Mice. Nutrients 2020, 12, 1848. [Google Scholar] [CrossRef]
  13. Li, P.; Yan, Z.; Chen, Y.; He, P.; Yang, W. Analysis of monosaccharide composition of water-soluble polysaccharides from Codium fragile by ultra-performance liquid chromatography-tandem mass spectrometry. J. Sep. Sci. 2021, 44, 1452–1460. [Google Scholar] [CrossRef]
  14. Kim, T.I.; Kim, Y.-J.; Kim, K. Extract of Seaweed Codium fragile Inhibits Integrin αIIbβ3-Induced Outside-in Signaling and Arterial Thrombosis. Front. Pharmacol. 2021, 12, 685948. [Google Scholar] [CrossRef]
  15. Park, H.-B.; Hwang, J.; Zhang, W.; Go, S.; Kim, J.; Choi, I.; You, S.; Jin, J.-O. Polysaccharide from Codium fragile Induces Anti-Cancer Immunity by Activating Natural Killer Cells. Mar. Drugs 2020, 18, 626. [Google Scholar] [CrossRef]
  16. Wang, L.; Oh, J.Y.; Je, J.G.; Jayawardena, T.U.; Kim, Y.-S.; Fu, X.; Jeon, Y.-J. Protective effects of sulfated polysaccharides isolated from the enzymatic digest of Codium fragile against hydrogen peroxide-induced oxidative stress in in vitro and in vivo models. Algal Res. 2020, 48, 101891. [Google Scholar] [CrossRef]
  17. Jiang, P.; Zheng, W.; Sun, X.; Jiang, G.; Wu, S.; Xu, Y.; Song, S.; Ai, C. Sulfated polysaccharides from Undaria pinnatifida improved high fat diet-induced metabolic syndrome, gut microbiota dysbiosis and inflammation in BALB/c mice. Int. J. Biol. Macromol. 2020, 167, 1587–1597. [Google Scholar] [CrossRef]
  18. Chen, C.-Y.; Wang, S.-H.; Huang, C.-Y.; Dong, C.-D.; Huang, C.-Y.; Chang, C.-C.; Chang, J.-S. Effect of molecular mass and sulfate content of fucoidan from Sargassum siliquosum on antioxidant, anti-lipogenesis, and anti-inflammatory activity. J. Biosci. Bioeng. 2021, 132, 359–364. [Google Scholar] [CrossRef]
  19. Fernando, I.P.S.; Sanjeewa, K.K.A.; Samarakoon, K.W.; Lee, W.W.; Kim, H.-S.; Kang, N.; Ranasinghe, P.; Lee, H.-S.; Jeon, Y.-J. A fucoidan fraction purified from Chnoospora minima; a potential inhibitor of LPS-induced inflammatory responses. Int. J. Biol. Macromol. 2017, 104, 1185–1193. [Google Scholar] [CrossRef]
  20. Sanjeewa, K.K.A.; Fernando, I.P.S.; Kim, E.-A.; Ahn, G.; Jee, Y.; Jeon, Y.-J. Anti-inflammatory activity of a sulfated polysaccharide isolated from an enzymatic digest of brown seaweed Sargassum horneri in RAW 264.7 cells. Nutr. Res. Pract. 2017, 11, 3–10. [Google Scholar] [CrossRef] [Green Version]
  21. Ni, L.; Wang, L.; Fu, X.; Duan, D.; Jeon, Y.-J.; Xu, J.; Gao, X. In vitro and in vivo anti-inflammatory activities of a fucose-rich fucoidan isolated from Saccharina japonica. Int. J. Biol. Macromol. 2020, 156, 717–729. [Google Scholar] [CrossRef] [PubMed]
  22. Asanka Sanjeewa, K.K.; Jayawardena, T.U.; Kim, H.-S.; Kim, S.-Y.; Shanura Fernando, I.P.; Wang, L.; Abetunga, D.T.U.; Kim, W.-S.; Lee, D.-S.; Jeon, Y.-J. Fucoidan isolated from Padina commersonii inhibit LPS-induced inflammation in macrophages blocking TLR/NF-κB signal pathway. Carbohydr. Polym. 2019, 224, 115195. [Google Scholar] [CrossRef] [PubMed]
  23. Rukshala, D.; de Silva, E.D.; Ranaweera, B.L.R.; Fernando, N.; Handunnetti, S.M. Anti-inflammatory effect of leaves of Vernonia zeylanica in lipopolysaccharide-stimulated RAW 264.7 macrophages and carrageenan-induced rat paw-edema model. J. Ethnopharmacol. 2021, 274, 114030. [Google Scholar] [CrossRef] [PubMed]
  24. Kim, J.-H.; Kim, M.; Hong, S.; Kwon, B.; Song, M.W.; Song, K.; Kim, E.-Y.; Jung, H.-S.; Sohn, Y. Anti-inflammatory effects of Fritillaria thunbergii Miquel extracts in LPS-stimulated murine macrophage RAW 264.7 cells. Exp. Ther. Med. 2021, 21, 429. [Google Scholar] [CrossRef] [PubMed]
  25. Kumar, S.; Singh, P.; Kumar, A. Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines. Clin. J. Gastroenterol. 2021, 15, 1–10. [Google Scholar] [CrossRef]
  26. Xu, Z.; Ke, T.; Zhang, Y.; Guo, L.; Chen, F.; He, W. Danshensu inhibits the IL-1β-induced inflammatory response in chondrocytes and osteoarthritis possibly via suppressing NF-κB signaling pathway. Mol. Med. 2021, 27, 80. [Google Scholar] [CrossRef] [PubMed]
  27. Liu, X.; Su, J.; Wang, G.; Zheng, L.; Wang, G.; Sun, Y.; Bao, Y.; Wang, S.; Huang, Y. Discovery of Phenolic Glycoside from Hyssopus cuspidatus Attenuates LPS-Induced Inflammatory Responses by Inhibition of iNOS and COX-2 Expression through Suppression of NF-κB Activation. Int. J. Mol. Sci. 2021, 22, 12128. [Google Scholar] [CrossRef]
  28. Wang, L.; Oh, J.Y.; Jayawardena, T.U.; Jeon, Y.-J.; Ryu, B. Anti-inflammatory and anti-melanogenesis activities of sulfated polysaccharides isolated from Hizikia fusiforme: Short communication. Int. J. Biol. Macromol. 2019, 142, 545–550. [Google Scholar] [CrossRef]
  29. Wang, L.; Oh, J.Y.; Hwang, J.; Ko, J.Y.; Jeon, Y.-J.; Ryu, B. In Vitro and In Vivo Antioxidant Activities of Polysaccharides Isolated from Celluclast-Assisted Extract of an Edible Brown Seaweed, Sargassum fulvellum. Antioxidants 2019, 8, 493. [Google Scholar] [CrossRef] [Green Version]
  30. Ko, E.-Y.; Cho, S.-H.; Kwon, S.-H.; Eom, C.-Y.; Jeong, M.S.; Lee, W.; Kim, S.-Y.; Heo, S.-J.; Ahn, G.; Lee, K.P.; et al. The roles of NF-κB and ROS in regulation of pro-inflammatory mediators of inflammation induction in LPS-stimulated zebrafish embryos. Fish Shellfish Immunol. 2017, 68, 525–529. [Google Scholar] [CrossRef]
Marinedrugs 20 00391 g001 550
Figure 1. Effect of CFCE-PS on LPS-induced cytotoxicity in RAW 264.7 cells. (A) The viability of LPS-stimulated RAW 264.7 cells; the production levels of NO (B) and PGE2 (C) in LPS-stimulated RAW 264.7 cells. The cells non-treated with CFCE-PS and LPS are referred to as the control group. The experiments were conducted in triplicate and the data are expressed as mean ± SE. * p < 0.05, ** p < 0.01 as compared to the LPS-stimulated group and ## p < 0.01 as compared to control group.
Figure 1. Effect of CFCE-PS on LPS-induced cytotoxicity in RAW 264.7 cells. (A) The viability of LPS-stimulated RAW 264.7 cells; the production levels of NO (B) and PGE2 (C) in LPS-stimulated RAW 264.7 cells. The cells non-treated with CFCE-PS and LPS are referred to as the control group. The experiments were conducted in triplicate and the data are expressed as mean ± SE. * p < 0.05, ** p < 0.01 as compared to the LPS-stimulated group and ## p < 0.01 as compared to control group.
Marinedrugs 20 00391 g001
Marinedrugs 20 00391 g002 550
Figure 2. Effect of CFCE-PS on the production of pro-inflammatory cytokines in LPS-stimulated RAW 264.7 cells. (A) Production of TNF-α; (B) production of IL-1β; and (C) production of IL-6. The cells non-treated with CFCE-PS and LPS are referred to as the control group. The experiments were conducted in triplicate and the data are expressed as mean ± SE. ** p < 0.01 as compared to LPS-stimulated group and ## p < 0.01 as compared to control group.
Figure 2. Effect of CFCE-PS on the production of pro-inflammatory cytokines in LPS-stimulated RAW 264.7 cells. (A) Production of TNF-α; (B) production of IL-1β; and (C) production of IL-6. The cells non-treated with CFCE-PS and LPS are referred to as the control group. The experiments were conducted in triplicate and the data are expressed as mean ± SE. ** p < 0.01 as compared to LPS-stimulated group and ## p < 0.01 as compared to control group.
Marinedrugs 20 00391 g002
Marinedrugs 20 00391 g003 550
Figure 3. Survival rate of zebrafish after being treated with CFCE-PS or/and with LPS. The zebrafish non-treated with CFCE-PS and LPS are referred to as the control group. The experiments were conducted in triplicate and the data are expressed as the mean ± SE. * p < 0.05, ** p < 0.01 as compared to the LPS-stimulated group and ## p < 0.01 as compared to the control group.
Figure 3. Survival rate of zebrafish after being treated with CFCE-PS or/and with LPS. The zebrafish non-treated with CFCE-PS and LPS are referred to as the control group. The experiments were conducted in triplicate and the data are expressed as the mean ± SE. * p < 0.05, ** p < 0.01 as compared to the LPS-stimulated group and ## p < 0.01 as compared to the control group.
Marinedrugs 20 00391 g003
Marinedrugs 20 00391 g004 550
Figure 4. Effect of CFCE-PS on inflammatory responses in LPS-induced zebrafish. (A) ROS level of LPS-stimulated zebrafish; (B) cell death of LPS-stimulated zebrafish; and (C) NO production in LPS-stimulated zebrafish. The zebrafish non-treated with CFCE-PS and LPS are referred to as the control group. The relative amounts of ROS, cell death, and NO of zebrafish were measured using ImageJ software. The experiments were conducted in triplicate and the data are expressed as the mean ± SE. * p < 0.05, ** p < 0.01 as compared to the LPS-treated group and ## p < 0.01 as compared to control group.
Figure 4. Effect of CFCE-PS on inflammatory responses in LPS-induced zebrafish. (A) ROS level of LPS-stimulated zebrafish; (B) cell death of LPS-stimulated zebrafish; and (C) NO production in LPS-stimulated zebrafish. The zebrafish non-treated with CFCE-PS and LPS are referred to as the control group. The relative amounts of ROS, cell death, and NO of zebrafish were measured using ImageJ software. The experiments were conducted in triplicate and the data are expressed as the mean ± SE. * p < 0.05, ** p < 0.01 as compared to the LPS-treated group and ## p < 0.01 as compared to control group.
Marinedrugs 20 00391 g004
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wang, L.; Je, J.-G.; Huang, C.; Oh, J.-Y.; Fu, X.; Wang, K.; Ahn, G.; Xu, J.; Gao, X.; Jeon, Y.-J. Anti-Inflammatory Effect of Sulfated Polysaccharides Isolated from Codium fragile In Vitro in RAW 264.7 Macrophages and In Vivo in Zebrafish. Mar. Drugs 2022, 20, 391. https://doi.org/10.3390/md20060391

AMA Style

Wang L, Je J-G, Huang C, Oh J-Y, Fu X, Wang K, Ahn G, Xu J, Gao X, Jeon Y-J. Anti-Inflammatory Effect of Sulfated Polysaccharides Isolated from Codium fragile In Vitro in RAW 264.7 Macrophages and In Vivo in Zebrafish. Marine Drugs. 2022; 20(6):391. https://doi.org/10.3390/md20060391

Chicago/Turabian Style

Wang, Lei, Jun-Geon Je, Caoxing Huang, Jae-Young Oh, Xiaoting Fu, Kaiqiang Wang, Ginnae Ahn, Jiachao Xu, Xin Gao, and You-Jin Jeon. 2022. "Anti-Inflammatory Effect of Sulfated Polysaccharides Isolated from Codium fragile In Vitro in RAW 264.7 Macrophages and In Vivo in Zebrafish" Marine Drugs 20, no. 6: 391. https://doi.org/10.3390/md20060391

APA Style

Wang, L., Je, J. -G., Huang, C., Oh, J. -Y., Fu, X., Wang, K., Ahn, G., Xu, J., Gao, X., & Jeon, Y. -J. (2022). Anti-Inflammatory Effect of Sulfated Polysaccharides Isolated from Codium fragile In Vitro in RAW 264.7 Macrophages and In Vivo in Zebrafish. Marine Drugs, 20(6), 391. https://doi.org/10.3390/md20060391

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop